TY - JOUR AU - Safioleas, M. AU - Lygidakis, N. J. AU - Manti, C. PY - 2007 DA - 2007// TI - Hepatitis B today JO - Hepatogastroenterology VL - 54 ID - Safioleas2007 ER - TY - JOUR AU - Poland, G. A. AU - Jacobson, R. M. PY - 2004 DA - 2004// TI - Clinical practice: prevention of hepatitis B with the hepatitis B vaccine JO - N Engl J Med VL - 351 UR - https://doi.org/10.1056/NEJMcp041507 DO - 10.1056/NEJMcp041507 ID - Poland2004 ER - TY - JOUR AU - Perz, J. F. AU - Armstrong, G. L. AU - Farrington, L. A. AU - Hutin, Y. J. AU - Bell, B. P. PY - 2006 DA - 2006// TI - The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide JO - J Hepatol VL - 45 UR - https://doi.org/10.1016/j.jhep.2006.05.013 DO - 10.1016/j.jhep.2006.05.013 ID - Perz2006 ER - TY - JOUR AU - Nash, K. PY - 2009 DA - 2009// TI - Telbivudine in the treatment of chronic hepatitis B JO - Adv Ther VL - 26 UR - https://doi.org/10.1007/s12325-009-0004-y DO - 10.1007/s12325-009-0004-y ID - Nash2009 ER - TY - JOUR AU - Bryant, M. L. AU - Bridges, E. G. AU - Placidi, L. AU - Faraj, A. AU - Loi, A. G. AU - Pierra, C. AU - Dukhan, D. AU - Gosselin, G. AU - Imbach, J. L. AU - Hernandez, B. PY - 2001 DA - 2001// TI - Antiviral L-nucleosides specific for hepatitis B virus infection JO - Antimicrob Agents Chemother VL - 45 UR - https://doi.org/10.1128/AAC.45.1.229-235.2001 DO - 10.1128/AAC.45.1.229-235.2001 ID - Bryant2001 ER - TY - JOUR AU - Lai, C. L. AU - Leung, N. AU - Teo, E. K. AU - Tong, M. AU - Wong, F. AU - Hann, H. W. AU - Han, S. AU - Poynard, T. AU - Myers, M. AU - Chao, G. PY - 2005 DA - 2005// TI - A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B JO - Gastroenterology VL - 129 UR - https://doi.org/10.1016/j.gastro.2005.05.053 DO - 10.1016/j.gastro.2005.05.053 ID - Lai2005 ER - TY - JOUR AU - Lai, C. L. AU - Gane, E. AU - Liaw, Y. F. AU - Hsu, C. W. AU - Thongsawat, S. AU - Wang, Y. AU - Chen, Y. AU - Heathcote, E. J. AU - Rasenack, J. AU - Bzowej, N. PY - 2007 DA - 2007// TI - Telbivudine versus lamivudine in patients with chronic hepatitis B JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMoa066422 DO - 10.1056/NEJMoa066422 ID - Lai2007 ER - TY - JOUR AU - Tang, D. C. AU - Xie, D. M. AU - Xu, J. J. AU - He, J. Y. AU - Yao, L. H. AU - Yang, Z. Z. AU - Li, Y. F. PY - 2009 DA - 2009// TI - Clinical Study on Telbivudine Treating Chronic Hepatitis B JO - Journal of Zhejiang University of Traditional Chinese Medicine VL - 33 ID - Tang2009 ER - TY - JOUR AU - Chen, S. X. AU - Hu, X. Z. AU - Zhu, F. AU - Wan, B. AU - Liu, P. PY - 2009 DA - 2009// TI - Therapeutic effect of 48 weeks of telbivudine on HBeAg-positive chronic hepatitis B JO - Infect Dis Info VL - 22 ID - Chen2009 ER - TY - JOUR AU - Hou, J. AU - Yin, Y. K. AU - Xu, D. AU - Tan, D. AU - Niu, J. AU - Zhou, X. AU - Wang, Y. AU - Zhu, L. AU - He, Y. AU - Ren, H. PY - 2008 DA - 2008// TI - Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial JO - Hepatology VL - 47 UR - https://doi.org/10.1002/hep.22075 DO - 10.1002/hep.22075 ID - Hou2008 ER - TY - JOUR AU - Zhong, X. H. AU - Liu, Y. AU - Xu, C. AU - Xu, L. M. AU - Wang, M. AU - Li, M. Z. PY - 2009 DA - 2009// TI - The study of efficacy and side effects of telbivudine and lamivudine for treatment of patients with chronic hepatitis B JO - Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases VL - 19 ID - Zhong2009 ER - TY - JOUR AU - Jadad, A. R. AU - Moore, R. A. AU - Carroll, D. AU - Jenkinson, C. AU - Reynolds, D. J. AU - Gavaghan, D. J. AU - McQuay, H. J. PY - 1996 DA - 1996// TI - Assessing the quality of reports of randomized clinical trials: is blinding necessary? JO - Control Clin Trials VL - 17 UR - https://doi.org/10.1016/0197-2456(95)00134-4 DO - 10.1016/0197-2456(95)00134-4 ID - Jadad1996 ER - TY - CHAP AU - Cai, W. PY - 2009 DA - 2009// TI - Efficacy and its influent factors of telbivudine or lamivudine treated with chronic hepatitis B patients BT - Shanghai Jiao Tong University school of medicine ID - Cai2009 ER - TY - JOUR AU - Yang, J. N. PY - 2009 DA - 2009// TI - A comparison of curative effect between telbivudine and lamivudine in patients with chronic hepatitis B virus JO - Chin J Prim Med Pharm VL - 16 ID - Yang2009 ER - TY - JOUR AU - Liaw, Y. F. AU - Gane, E. AU - Leung, N. AU - Zeuzem, S. AU - Wang, Y. AU - Lai, C. L. AU - Heathcote, E. J. AU - Manns, M. AU - Bzowej, N. AU - Niu, J. PY - 2009 DA - 2009// TI - 2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B JO - Gastroenterology VL - 136 UR - https://doi.org/10.1053/j.gastro.2008.10.026 DO - 10.1053/j.gastro.2008.10.026 ID - Liaw2009 ER - TY - JOUR AU - Jia, J. D. AU - Hou, J. L. AU - Yin, Y. K. AU - Xu, D. Z. AU - Tan, D. AU - Niu, J. AU - Zhou, X. Q. AU - Wang, Y. AU - Zhu, L. AU - Brown, N. PY - 2007 DA - 2007// TI - Two-year results of a phase III comparative trial of telbivudine vs lamivudine in chinese patients JO - Journal of Hepatology VL - 46 UR - https://doi.org/10.1016/S0168-8278(07)62095-9 DO - 10.1016/S0168-8278(07)62095-9 ID - Jia2007 ER - TY - JOUR AU - Rasenack, J. AU - Poynard, T. AU - Lai, C. L. AU - Gane, E. AU - Brown, N. A. AU - Heathcote, J. PY - 2007 DA - 2007// TI - Efficacy of telbivudine vs lamivudine at 2 years in patinents with HbeAg-positive chronic hepatitis B who are eligible for treatment based on guidelines JO - Journal of Hepatology VL - 46 UR - https://doi.org/10.1016/S0168-8278(07)62111-4 DO - 10.1016/S0168-8278(07)62111-4 ID - Rasenack2007 ER - TY - JOUR AU - Lavanchy, D. PY - 2004 DA - 2004// TI - Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures JO - J Viral Hepat VL - 11 UR - https://doi.org/10.1046/j.1365-2893.2003.00487.x DO - 10.1046/j.1365-2893.2003.00487.x ID - Lavanchy2004 ER - TY - JOUR AU - Liaw, Y. F. PY - 2009 DA - 2009// TI - Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia JO - J Hepatol VL - 51 UR - https://doi.org/10.1016/j.jhep.2009.04.003 DO - 10.1016/j.jhep.2009.04.003 ID - Liaw2009 ER - TY - JOUR AU - Juni, P. AU - Altman, D. G. AU - Egger, M. PY - 2001 DA - 2001// TI - Systematic reviews in health care: Assessing the quality of controlled clinical trials JO - BMJ VL - 323 UR - https://doi.org/10.1136/bmj.323.7303.42 DO - 10.1136/bmj.323.7303.42 ID - Juni2001 ER - TY - JOUR AU - Bauer, P. AU - Koenig, F. AU - Brannath, W. AU - Posch, M. PY - 2010 DA - 2010// TI - Selection and bias--two hostile brothers JO - Stat Med VL - 29 ID - Bauer2010 ER - TY - JOUR AU - Thornton, A. AU - Lee, P. PY - 2000 DA - 2000// TI - Publication bias in meta-analysis: its causes and consequences JO - J Clin Epidemiol VL - 53 UR - https://doi.org/10.1016/S0895-4356(99)00161-4 DO - 10.1016/S0895-4356(99)00161-4 ID - Thornton2000 ER - TY - JOUR AU - Egger, M. AU - Zellweger-Zahner, T. AU - Schneider, M. AU - Junker, C. AU - Lengeler, C. AU - Antes, G. PY - 1997 DA - 1997// TI - Language bias in randomised controlled trials published in English and German JO - Lancet VL - 350 UR - https://doi.org/10.1016/S0140-6736(97)02419-7 DO - 10.1016/S0140-6736(97)02419-7 ID - Egger1997 ER -